Related Experiment Videos

The burden of illness of hypertension and comorbid diabetes

Michael T Eaddy1, Manan Shah, Orsolya Lunacsek

  • 1Xcenda, Palm Harbor, FL 34685, USA. michael.eaddy@xcenda.com

Current Medical Research and Opinion
|August 2, 2008
PubMed

Insights

Comorbid hypertension and diabetes significantly increase healthcare costs and resource utilization compared to managing either condition alone. Patients with both conditions incurred substantially higher disease-specific expenses and experienced more cardiovascular events.

Area of Science:

  • Health Economics
  • Cardiovascular Disease Management
  • Diabetes Mellitus Research

Background:

  • Hypertension (HTN) and diabetes mellitus (DM) are prevalent chronic conditions.
  • Comorbidities of HTN and DM can significantly impact patient outcomes and healthcare resource utilization.
  • Understanding the economic burden of combined HTN and DM is crucial for healthcare planning.

Purpose of the Study:

  • To compare the economic impact of comorbid hypertension and diabetes mellitus against managing each condition individually.
  • To assess differences in resource utilization and healthcare costs between HTN-only, DM-only, and comorbid HTN+DM cohorts.
  • To quantify the incremental costs associated with managing combined cardiovascular and metabolic disease states.

Main Methods:

  • Retrospective claims analysis of patients without pre-existing cardiovascular disease.
  • Three cohorts: newly-treated HTN-only, DM-only, and newly-treated HTN+DM.
  • Total, cardiovascular-specific, and DM-specific costs analyzed over 24 months across inpatient, outpatient, ED, physician, and pharmacy categories.
  • Linear regression used for cost comparison, controlling for baseline demographics and comorbidities.

Main Results:

  • The comorbid HTN+DM cohort exhibited the highest inpatient, outpatient, ED, other medical, and pharmacy costs.
  • Comorbid patients incurred significantly higher cardiovascular and DM-specific costs compared to single-condition cohorts.
  • At 24 months, HTN-related costs were $2678 and DM-related costs were $3094 for the comorbid group, exceeding single-condition costs by over $1000 and $1800, respectively.
  • Post-hoc analysis revealed a higher incidence of myocardial infarctions and acute ischemic events in the comorbid cohort.

Conclusions:

  • Comorbid hypertension and diabetes are associated with substantially higher healthcare costs and resource utilization.
  • The increased costs in comorbid patients reflect an intensified care requirement beyond managing individual diseases.
  • Administrative database analyses may be subject to patient selection biases, warranting careful interpretation.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.